Search
for
Sort by
Research 511–540 of 1000+
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Menopause and aging, quality of life and sexuality
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Gender aspects in skin diseases
- Hair follicles, their disorders and their opportunities
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- Biology of Hair Growth
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Female type of adult acne: Physiological and psychological considerations and management
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Synaptic Long-Term Potentiation and Depression in the Rat Medial Vestibular Nuclei Depend on Neural Activation of Estrogenic and Androgenic Signals
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone
- Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS
- Dermatologic Conditions in Transgender Populations
- Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Medical Options for Care of Gender Diverse and Transgender Youth
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Antiandrogenic activities of<i>Glycyrrhiza glabra</i>in male rats
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Targets to treat androgen excess in polycystic ovary syndrome
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Dermatosis associated with menopause
- Microemulsions as Carriers for Therapeutic Molecules
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)